News
- Author:
- Will Pass
Publish date: July 15, 2019
Triple therapy with an inhaled corticosteroid is particularly helpful for patients with chronic obstructive pulmonary disease (COPD) who have high ...
News
- Author:
- Will Pass
Publish date: July 12, 2019
In a retrospective study involving 16,228 patients with NSCLC, patients treated with immunotherapy had a significantly longer median overall surviv...
News
- Author:
- Will Pass
Publish date: July 8, 2019
Surveillance twice a year of all patients with F3 or F4 fibrosis had a less than 1% chance of remaining under a $50,000 per QALY willingness-t...
News
- Author:
- Will Pass
Publish date: July 3, 2019
Drug treatments may be developed for cancers that genetic analyses have identified as having different methylation subtypes.
News
- Author:
- Will Pass
Publish date: July 2, 2019
With underwater endoscopic mucosal resection, the bowel lumen is filled with water instead of air/CO2.
News
- Author:
- Will Pass
Publish date: July 1, 2019
Weight loss interventions were associated with significantly decreased alanine aminotransferase.
News
- Author:
- Will Pass
Publish date: July 1, 2019
Weight loss interventions were associated with significantly decreased alanine aminotransferase.
News
- Author:
- Will Pass
Publish date: June 27, 2019
Clinicians may now consider prescribing gluten-free diets to only the highest-risk patients, instead of all suspected cases, noting that more than ...
News
- Author:
- Will Pass
Publish date: June 27, 2019
All published cohort studies to date have not been able to confirm a significant benefit to combination therapy in UC.
News
- Author:
- Will Pass
Publish date: June 27, 2019
AMSTERDAM – Patients treated with gilteritinib has superior overall survival, compared with four salvage chemotherapy regimens.
News
- Author:
- Will Pass
Publish date: June 26, 2019
AMSTERDAM – In order to see this limited advantage with guadecitabine, patients had to undergo at least four cycles of treatment.
News
- Author:
- Will Pass
Publish date: June 26, 2019
AMSTERDAM – The investigators called for randomized testing to compare the combination to standard chemotherapy in the frontline setting for hairy ...
News
- Author:
- Will Pass
Publish date: June 26, 2019
AMSTERDAM – VTE risk modeling is available for patients with solid tumors, but a similar prognostic tool for leukemia patients has been missing.
News
- Author:
- Will Pass
Publish date: June 25, 2019
AMSTERDAM – The findings mean clinicians can look to complete blood count for answers on thromboembolism risk.
News
- Author:
- Will Pass
Publish date: June 25, 2019
AMSTERDAM – The addition of selinexor looks promising in relapsed/refractory AML, but Karyopharm Therapeutics will be focusing first on approval of...
